Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized trial of three hepatitis B vaccination schedules in HIV-infected adults with CD4 >200/mm3
2006-003940-50Phase 3Completed
- Sponsor
- ANRS
- Start
- Dec 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of recombinant hepatitis B vaccine Bio Farma in hepatitis B (HBV) (3 arms), sponsored by ANRS. Primary endpoint: Primary immunogenicity endpoint. Started Dec 2006; status: completed.
02
Drugs
recombinant hepatitis B vaccine Bio Farma
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2006-003940-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003940-50.